Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 2/20 | 0.41 |
| ▸ | CTRC | Q99895 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | NOS1 | P29475 | 2/20 | 0.40 |
| ▸ | NOS2 | P35228 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22643587 | 1.00 | PRSS1 (0.41) | PRSS1CTRCF2NOS1NOS2 | |
| SCHEMBL577127 | 0.94 | NOS1 (0.42) | PRSS1CTRCF2NOS1NOS2 | |
| SCHEMBL576860 | 0.88 | — | — | |
| SCHEMBL11915557 | 0.82 | KCNH3 (0.31) | — | |
| SCHEMBL10431427 | 0.81 | FAAH (0.38) | PRSS1CTRCF2FAAH | |
| SCHEMBL27706139 | 0.80 | PRSS1 (0.35) | PRSS1CTRCF2 | |
| Acetic Acid SCHEMBL11034851 | 0.79 | FAAH (0.36) | PRSS1CTRCF2FAAH | |
| SCHEMBL5013295 | 0.79 | FAAH (0.41) | PRSS1CTRCF2FAAH | |
| SCHEMBL20980149 | 0.78 | NOS1 (0.41) | PRSS1CTRCF2NOS1NOS2 | |
| SCHEMBL24829919 | 0.78 | NOS2 (0.33) | NOS1NOS2FKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240368351-A1 | FACTORS CONTROLLING DRUG RELEASE IN CROSS-LINKED POLY(VALEROLACTONE) BASED MATRICES | PENDANT BIOSCIENCES INC (US) | 2024-11-07 | — | — | US | claimed |
| US-11905377-B2 | Factors controlling drug release in cross-linked poly(valerolactone) based matrices | PENDANT BIOSCIENCES, INC. (US) | 2024-02-20 | — | — | US | claimed |
| US-20140371403-A1 | STENT FORMED FROM CROSSLINKED BIOABSORBABLE POLYMER | ABBOTT CARDIOVASCULAR SYSTEMS (US) | 2014-12-18 | — | — | US | claimed |
| US-8679396-B2 | Method of making a stent formed from crosslinked bioabsorbable polymer | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2014-03-25 | — | — | US | claimed |
| US-20120149850-A1 | STENT FORMED FROM CROSSLINKED BIOABSORBABLE POLYMER | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-06-14 | — | — | US | claimed |
| US-20120150283-A1 | METHOD OF MAKING A STENT FORMED FROM CROSSLINKED BIOABSORBABLE POLYMER | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-06-14 | — | — | US | claimed |
| US-8147744-B2 | Method of making a stent formed from crosslinked bioabsorbable polymer | ABBOTT CARDIOVASCULAR SYSTEMS INC. (US) | 2012-04-03 | — | — | US | claimed |
| EP-2266967-A1 | Intermediates for the preparation of octahydroquinolizines | 55pharma Drug Discovery & Development AG (AT) | 2010-12-29 | — | — | EP | claimed |
| WO-2010144937-A2 | INTERMEDIATES FOR THE PREPARATION OF OCTAHYDROQUINOLIZINES | 55PHARMA DRUG DISCOVERY & DEVELOPMENT AG (AT) | 2010-12-23 | — | — | WO | claimed |
| US-20100262223-A1 | Stent Formed from Crosslinked Bioabsorbable Polymer and Methods of Making the Stent | ABBOTT CARDIOVASCULAR SYSTEMS INC. | 2010-10-14 | — | — | US | claimed |
| US-6346599-B1 | CONDENSATION POLYMERIZATION OF LACTONE MIXTURE WITH INHIBITION OF CRYSTALLIZATION | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2002-02-12 | — | — | US | claimed |
| EP-0559789-A1 | PROCESS FOR THE PREPARATION OF $g(a)-ALKYL LACTONES | HENKEL CORPORATION (US) | 1993-09-15 | — | — | EP | claimed |
| WO-1992009590-A1 | PROCESS FOR THE PREPARATION OF α-ALKYL LACTONES | HENKEL CORPORATION (US) | 1992-06-11 | — | — | WO | claimed |
| US-20240368351-A1 | FACTORS CONTROLLING DRUG RELEASE IN CROSS-LINKED POLY(VALEROLACTONE) BASED MATRICES | PENDANT BIOSCIENCES INC (US) | 2024-11-07 | — | — | US | disclosed |
| US-20240368351-A1 | FACTORS CONTROLLING DRUG RELEASE IN CROSS-LINKED POLY(VALEROLACTONE) BASED MATRICES | PENDANT BIOSCIENCES INC (US) | 2024-11-07 | — | — | US | disclosed |
| US-11905377-B2 | Factors controlling drug release in cross-linked poly(valerolactone) based matrices | PENDANT BIOSCIENCES, INC. (US) | 2024-02-20 | — | — | US | disclosed |
| EP-0024682-B1 | PROCESS FOR THE PREPARATION OF N-PROPYL-N-PROPYLIDENE ACETAMIDE OR DI-N-PROPYL ACETAMIDE | Consortium für elektrochemische Industrie GmbH (DE) | 1982-12-22 | — | — | EP | disclosed |
| EP-0003846-B1 | A PROCESS FOR PRODUCING A CROSSLINKABLE COPOLYMER OF A LACTONE AND A POLYFUNCTIONAL ACRYLATE, THE SO OBTAINED COPOLYMER, A METHOD FOR THE MANUFACTURE OF ARTICLES THEREFROM AND THE SO FORMED ARTICLES | UNION CARBIDE CORPORATION (US) | 1982-10-20 | — | — | EP | disclosed |
| US-4315011-A | VASODILATORS | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1982-02-09 | — | — | US | disclosed |
| EP-0024682-A1 | Process for the preparation of n-propyl-n-propylidene acetamide or di-n-propyl acetamide | Consortium für elektrochemische Industrie GmbH (DE) | 1981-03-11 | — | — | EP | disclosed |